Belt dystrophy 2G

from Wikipedia, the free encyclopedia
Classification according to ICD-10
G71.0 Muscular dystrophy
- pelvic or shoulder girdle shape
ICD-10 online (WHO version 2019)

The limb-2G (LGMD2G) is a very rare disease from the group of limb-girdle muscular dystrophy .

Cause and development of the disease

The LGMD2G is caused by mutations in the TCAP gene (the human chromosome 17, 17q12) gives and autosomal - recessive inherited. TCAP codes for the protein telethonin (titin cap protein). The disease is therefore also known as telethoninopathy . The protein telethonin is produced in the skeletal and heart muscles. It is a sarcomere protein associated with titin and the Z-slices of muscle fibers . So far, homozygous as well as compound heterozygous mutations in the TCAP gene have been described as the cause.

Clinical manifestations

Clinically, the disease is characterized by proximal muscle weakness and the involvement of distal muscle groups and often the heart muscles. The disease usually manifests itself within the second decade of life. Due to the involvement of the distal muscles, the LGMD2G shows similarities with the Miyoshi myopathy .

Investigation methods

The creatine kinase in the serum can be slightly to significantly increased. Typical but unspecific dystrophic changes can be found histologically. Occasionally, "rimmed" vacuoles can be detected, which can lead to confusion with other muscle diseases such as inclusion body myositis and myofibrillary myopathy . A deficiency in telethonin is possible with Western blot analysis or immunohistochemistry . The diagnosis is confirmed by molecular genetics .

treatment

A causal therapy is not known, so symptomatic measures such as physiotherapy are in the foreground.

literature

Individual evidence

  1. UniProt O15273

Web links